成人心脏骤停的目标温度管理:系统评价与荟萃分析
该系统评价与荟萃分析检索至2021年6月17日,纳入32项临床试验,评估成人心脏骤停后目标温度管理的时机、温度、时长、诱导与维持方法及复温。32-34℃目标温度管理对比常温(常需主动降温)未改善90-180天生存(RR 1.08, 95%CI 0.89-1.30)或良好神经结局(RR 1.21, 95%CI 0.91-1.61),证据确定性低。不同低温目标间无差异(低确定性)。院前降温对比无院前降温未改善出院生存(RR 1.01, 95%CI 0.92-1.11)或良好神经结局(RR 1.00, 95%CI 0.90-1.11),证据确定性中等。结论提示需更新国际心脏骤停指南。
要点
- 成人心脏骤停后32-34℃目标温度管理对比常温,90-180天生存RR 1.08(95%CI 0.89-1.30),无改善。
- 32-34℃目标温度管理对比常温,90-180天良好神经结局RR 1.21(95%CI 0.91-1.61),无改善,证据确定性低。
- 院前启动降温对比无院前降温,出院生存RR 1.01(95%CI 0.92-1.11),良好神经结局RR 1.00(95%CI 0.90-1.11),均无获益。
- 不同低温目标温度之间比较,结局无差异,证据确定性低。
- 多数结局偏倚风险评为中等,结论提示需更新国际心脏骤停指南。
适用人群与场景
- 成人心脏骤停患者,涵盖院前及院内场景,涉及目标温度管理的时机、温度、时长、诱导与维持方法及复温等各方面。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及具体药物剂量、给药途径、频次或目标值;仅评估目标温度管理策略,包括目标温度32-34℃对比常温、不同低温目标间比较、院前降温对比无院前降温。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 系统评价与荟萃分析,检索PubMed、Embase、Cochrane Central于2021年6月17日,纳入32项临床试验,多数结局偏倚风险中等,采用随机效应模型合并,GRADE评估证据确定性。
- 32-34℃目标温度管理对比常温(常需主动降温):9项试验识别,6项纳入荟萃分析,90-180天生存RR 1.08(95%CI 0.89-1.30),良好神经结局RR 1.21(95%CI 0.91-1.61),证据确定性低。
- 不同低温目标温度比较:3项试验,结局无差异,证据确定性低。
证据类型、等级与局限
- 系统评价与荟萃分析,纳入32项临床试验,GRADE评估证据确定性:32-34℃对比常温为低确定性,不同低温目标间比较为低确定性,院前降温对比无院前降温为中等确定性;多数结局偏倚风险中等。
- 局限:原文未具体说明各试验的设计类型、单中心或多中心、样本量、开放标签与否等细节。
对床旁实践的改变
- 成人心脏骤停后不常规以32-34℃目标温度管理替代常温来改善生存或神经结局,因荟萃分析未显示获益。
- 院前不启动降温以改善出院生存或神经结局,因无获益。
- 不同低温目标温度间无差异,选择具体低温目标时无证据支持某一目标更优。
- 结论提示需更新国际心脏骤停指南。
指南或共识出处
- 原文未提及具体指南或共识名称;结论提及需更新国际心脏骤停指南。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To perform a systematic review and meta-analysis on targeted temperature management in adult cardiac arrest patients.
METHODS: PubMed, Embase, and the Cochrane Central Register of Controlled Trials were searched on June 17, 2021 for clinical trials. The population included adult patients with cardiac arrest. The review included all aspects of targeted temperature management including timing, temperature, duration, method of induction and maintenance, and rewarming. Two investigators reviewed trials for relevance, extracted data, and assessed risk of bias. Data were pooled using random-effects models. Certainty of evidence was evaluated using GRADE.
RESULTS: The systematic search identified 32 trials. Risk of bias was assessed as intermediate for most of the outcomes. For targeted temperature management with a target of 32-34 °C vs. normothermia (which often required active cooling), 9 trials were identified, with six trials included in meta-analyses. Targeted temperature management with a target of 32-34 °C did not result in an improvement in survival (risk ratio: 1.08 [95%CI: 0.89, 1.30]) or favorable neurologic outcome (risk ratio: 1.21 [95%CI: 0.91, 1.61]) at 90 to 180 days after the cardiac arrest (low certainty of evidence). Three trials assessed different hypothermic temperature targets and found no difference in outcomes (low certainty of evidence). Ten trials were identified comparing prehospital cooling vs. no prehospital cooling with no improvement in survival (risk ratio: 1.01 [95%CI: 0.92, 1.11]) or favorable neurologic outcome (risk ratio: 1.00 [95%CI: 0.90, 1.11]) at hospital discharge (moderate certainty of evidence).
CONCLUSIONS: Among adult patients with cardiac arrest, the use of targeted temperature management at 32-34 °C, when compared to normothermia, did not result in improved outcomes in this meta-analysis. There was no effect of initiating targeted temperature management prior to hospital arrival. These findings warrant an update of international cardiac arrest guidelines.
参考来源
- Granfeldt A, Holmberg MJ, Nolan JP, et al. Targeted temperature management in adult cardiac arrest: Systematic review and meta-analysis. Resuscitation. 2021. PMID: 34474143. doi:10.1016/j.resuscitation.2021.08.040
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。